By Admin 
Donald Trump Pharma Tariff: US President Donald Trump announced to impose 100 percent tariffs on the import of branded and patent drugs last week. It is expected to be implemented from October 1, 2025. Companies were excluded from the purview of this tariff, who are building their manufacturing plant in America. Its purpose is to encourage domestic production of drugs in America and eliminate dependence on foreign companies. However, even after the passing of October 1, this tariff did not apply, why? Let’s know
Why the delay in implementing tariffs?
The reason behind this delay is that Trump’s government wants to bring their manufacturing on track by interacting with pharmaceutical companies before putting tariffs. Also, proposals to reduce the prices of medicines of many companies are also being considered. It has been said by the White House that since the talks are still going on, there is a delay in implementing the tariff, but can be implemented in future. That is, its danger is not completely averted yet. If Trump’s 100 percent pharma tariff is implemented, medicines imported from abroad will become expensive for patients. Axperts also say that this may spoil the relationship between trade partners and can cause interruptions in the global supply chain.
Fizzer deal with Trump administration
Meanwhile, Pharmazer, a large company in the pharmaceutical industry, has said to invest $ 70 billion in the US under a deal with the US government. Also promised to reduce the prices of medicines. This shows that the company is trying to increase the scope of its work in America. Meanwhile, Pharmazer, a large company in the pharmaceutical industry, has said to invest $ 70 billion in the US under a deal with the US government. Also promised to reduce the prices of medicines. This shows that the company is trying to increase the scope of its work in America.
#Breakingnews: Today, Pfizer Announced a Historic and Voluntary Agreement with @Potus That will ensure American Patients pay lower pris for their prescription medicines. With this agreement in place, we can invest even more boldly in the US – fueling growth, creating jobs,… pic.twitter.com/im8bjl7yxq
– Pfizer Inc. (@Pfizer) September 30, 2025
Preparation for launch website in the name of Trump
According to a report, in the meantime, Trump’s government is thinking about launching a website that will mention the medicine given on a discount. With the help of this website, patients will help in purchasing medicines at discounts directly from companies. It can be named ‘Trumprx’. That is, it will act like a search tool, through which the patients will know how much discount on which platform is being given on which medicine.
Also read:
Is India scared of Trump’s threats? Russia reduced oil purchases in September, government companies reduced imported